Page 130 - ESHRE2019

TUESDAY, 25 JUNE 2019
SELECTED ORAL COMMUNICATIONS
15:15 - 16:30 Haydn 1
Session 50: The luteal phase
Chairs:
15:15
15:30
15:45
16:00
G. Griesinger (Germany) M. Sator (Austria)
O-173 A large prospective trial in unselected population confirms that low serum progesterone on the day of embryo transfer impairs pregnancy outcome in artificial cycles
E. Labarta Demur1, G. Mariani2, S. Paolelli2, C. Vidal2, J. Giles2, J. Bellver2, F. Cruz2, A. Marzal2, P. Celada2, I. Olmo2, P. Alamá2, J. Remohí2, E. Bosch2
1IVI RMA Valencia, Human Reproduction, Valencia, Spain 2IVI-RMA Valencia, Human Reproduction, Valencia, Spain
O-174 Cabergoline versus calcium gluconate infusion in the prevention of ovarian hyperstimulation syndrome. A randomized controlled trial
H. El-Shaer1,2, U. Fouda1,2, G. Youssef1, A. Hanafy1, H. Nabil1, W. Mehrem3
1Cairo University- Faculty of medicine, Obstetrics and Gynecology Department, Giza, Egypt 2Riyadh fertility and reproductive health center, Assisted conception unit, Giza, Egypt
3Al Gazeera hospital, Assisted conception unit, Giza, Egypt
O-175 Clinical pregnancy rates among anovulatory and oligoovulatory women after letrozole versus hormone replacement therapy in frozen-thawed embryo transfer cycles
M. Sharon-weiner1, S. Farladansky-Gershnabel1, A. Berkovitch1 1Meir Medical Center, Obstetrics and Gynecology, Kfar Saba, Israel
O-176 The luteal phase of double ovarian stimulation treatment (DuoStim) provides higher oocyte and blastocyst yield in unselected infertile patients: a retrospective, same-patient, cohort study
D. Bodri1, J.C. Castillo1, B. Moliner1, J. Llácer1, A. Fuentes1, P. Cirillo1, Á. Llaneza2, J. Ten1, A. Bernabeu1, R. Bernabeu1
1Instituto Bernabeu, Assisted Reproduction Unit, Alicante, Spain 2Instituto Bernabeu, Assisted Reproduction Unit, Madrid, Spain
130